For the first time in Nepal, genetic testing, also known as "Gene Sequencing," related to breast cancer (BRCA1 and BRCA2) has ...

Mutations in the BRCA gene are one example ... is starting to apply multi-omic technologies to characterize other types of cancer cells. Multi-omics can also be used to compare preclinical ...

People who learn that they carry worrisome BRCA1 mutations need better options to either prevent cancer from developing or intercept it at an early stage. This is particularly crucial for reducing ...

Australians with prostate and breast cancer now have affordable access to affordable new and expanded medicines under the ...

This can lead to cancer developing. Faulty BRCA1 and BRCA2 genes are rare. Only around 1 in every 400 people have a faulty BRCA1 or BRCA2 gene. Both men and women can have a faulty BRCA1 or BRCA2 gene ...

The concept of surveillance is based on early detection of cancer rather than cancer ... a similar extent of damage in both BRCA1 mutant and wild-type cells. The recent discovery that PARP-1 ...

For cancer-suppressor genes like BRCA1, researchers have long hypothesized that a single healthy copy could still guard against tumor development. Yet women with one harmful BRCA1 mutation are far ...

"So, I got the results back. It was positive for BRCA1 and that's the one that makes you more high risk for breast and ovarian [cancer]," Feldman said. For years, she sat on the information.

Researchers at Tel Aviv University have developed a new platform using polymeric nanoparticles to deliver drug pairs to ...

Researchers at Tel Aviv University have developed a new platform using polymeric nanoparticles to deliver drug pairs to specific cancer types, including skin cancer and breast cancer.